Occupational exposure to unintentionally emitted nanoscale particles and risk of cancer: From lung to central nervous system - Results from three French case-control studies.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
12 2020
Historique:
received: 11 02 2020
revised: 20 07 2020
accepted: 28 07 2020
pubmed: 11 8 2020
medline: 12 1 2021
entrez: 11 8 2020
Statut: ppublish

Résumé

Nanoscale particles (1-100 nm) can be of natural origin, and either intentionally or unintentionally produced by human activities. Toxicological data have suggested a possible carcinogenic effect of such particles. The aim of this study was to estimate the association between occupational exposure to nanoscale particles and risk of lung cancer, pleural mesothelioma and brain tumors in adults. Three French population-based case-control studies were analyzed: 1) the ICARE study including 2029 lung cancer cases and 2591 controls; 2) the PNSM study including 371 pleural mesothelioma cases and 730 controls and 3) the CERENAT study including 257 brain tumor cases and 511 controls. Occupational exposure to unintentionally emitted nanoscale particles (UNPs) was retrospectively assessed by a job exposure matrix providing a probability and a frequency of exposure. In adjusted analyses among men, significant associations between occupational exposure to UNPs and lung cancer (OR = 1.51; 95% CI: 1.22-1.86 and brain tumors (OR = 1.69; 95% CI: 1.17-2.44) were observed. No increased OR was observed for pleural mesothelioma (OR = 0.78; 95% CI: 0.46-1.33). This is the first study showing positive associations between occupational exposure to UNPs and increased risk of lung cancer and brain tumors. These preliminary results should encourage further epidemiological research.

Identifiants

pubmed: 32777272
pii: S0013-9351(20)30921-X
doi: 10.1016/j.envres.2020.110024
pii:
doi:

Substances chimiques

Asbestos 1332-21-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110024

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Guyguy Manangama (G)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, F-33000, Bordeaux, France.

Céline Gramond (C)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, F-33000, Bordeaux, France.

Sabyne Audignon-Durand (S)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, F-33000, Bordeaux, France.

Isabelle Baldi (I)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, F-33000, Bordeaux, France.

Pascale Fabro-Peray (P)

CHU Nîmes, BESPIM, F-30029, Nîmes, France.

Annabelle Gilg Soit Ilg (A)

Santé Publique France, Direction Santé Travail, F-94415, Saint-Maurice Cedex, France.

Pascal Guénel (P)

Centre de Recherche en Epidémiologie et Santé des Populations (CESP), Cancer and Environment Team, Université Paris-Sud, Université Paris-Saclay, F-94800, Villejuif, France.

Pierre Lebailly (P)

ANTICIPE, U1086 INSERM, Université de Caen Normandie, And Centre de Lutte Contre le Cancer François Baclesse, F-14000, Caen, France.

Danièle Luce (D)

Université de Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S, 1085, Pointe-à-Pitre, France.

Isabelle Stücker (I)

Centre de Recherche en Epidémiologie et Santé des Populations (CESP), Cancer and Environment Team, Université Paris-Sud, Université Paris-Saclay, F-94800, Villejuif, France.

Patrick Brochard (P)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, F-33000, Bordeaux, France.

Aude Lacourt (A)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, UMR 1219, F-33000, Bordeaux, France. Electronic address: aude.lacourt@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH